Thymosin Alpha-1 "TA-1" (10mg) Injectable

Immune Enhancement: TA-1 is well-known for its ability to boost the immune system by increasing T-cell production and activity, improving the body’s ability to fight infections and bolster overall immune function.

Reduced Inflammation: TA-1 helps modulate the immune system and downregulate pro-inflammatory cytokines, making it effective for managing inflammation associated with autoimmune diseases and chronic conditions.

Antiviral Defense: This peptide has antiviral properties that enhance the body's natural defenses, making it beneficial for combating viral infections, including respiratory illnesses and chronic viral conditions.

Cancer Support: TA-1 is used adjunctively in some cancer treatments due to its ability to stimulate immune cells, potentially improving immune surveillance and the body's capacity to fight abnormal cells.

Chronic Fatigue Support: It has been shown to improve energy levels and alleviate fatigue, especially in conditions where immune dysfunction or chronic infection is present.

Autoimmune Modulation: TA-1 helps balance the immune system by promoting immune tolerance, reducing the severity of autoimmune responses, and supporting the management of autoimmune conditions.

Active Cancer without Consultation: While TA-1 is sometimes used as an adjunct in cancer treatment, it should not be used without consultation with a healthcare provider due to its immune-stimulating effects.

Pregnant or Breastfeeding Women: The safety of TA-1 during pregnancy or breastfeeding has not been established, so it is not recommended for these populations unless under medical supervision.

Immune System Deficiencies: Effective in boosting immune function in individuals with weakened or compromised immune systems, including those recovering from chronic infections or facing recurrent illnesses.

Chronic Viral Infections: Provides support for individuals dealing with chronic viral infections like hepatitis, Epstein-Barr virus, and others, helping reduce viral loads and improve immune responses.

Autoimmune Disorders: Modulates the immune system, making it useful for managing autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus (SLE).

Chronic Fatigue Syndrome: Alleviates fatigue and improves energy levels, making it helpful for conditions like chronic fatigue syndrome (CFS) and other fatigue-related disorders.

Cancer Recovery: As an adjunct to cancer therapy, TA-1 supports the immune system during treatment, potentially enhancing the body’s ability to target abnormal cells.
Long COVID Recovery: Assists in managing lingering symptoms of long COVID, particularly fatigue, immune dysregulation, and general weakness by strengthening the body’s natural defenses.

Dosing: 0.5 mg = 20 units per injection.

Injections Per Week: 5 injections weekly.

Recommended Cycles: 1 month on (+), 3 months off (-). 3 cycles per year.

Vial Details: 10mg / 4mL

Vial Duration: 4 Weeks

Injection Site: Administer injections into subcutaneous fat (such as the stomach, thigh, or arm).

Time of Day: TA-1 can be injected any time of day. Some people prefer doing it in the morning or evening, depending on patient preference or how it fits into their routine.

Injection Site Reactions: Some individuals may experience mild redness, swelling, or discomfort at the injection site; these reactions are generally temporary and resolve on their own.

Systemic Symptoms: Although rare, a few patients have reported fatigue, headache, or gastrointestinal discomfort following TA-1 administration.

Please contact us if you experience any of the following:
- Fever of 100.4°F (38°C) or higher
- Blistering at the injection site
- Muscle aches, nausea, dizziness, or headache
- Skin rash, severe itching, vomiting, or hives

If you have any questions, feel free to message your healthcare provider through the patient portal or contact us at 646-596-7386.

Start with a Lower Dose: Begin with a lower dose to assess tolerance, gradually increasing as recommended by a healthcare provider.

Rotate Injection Sites: Change the injection site with each dose to prevent irritation and minimize discomfort.

Stay Hydrated: Proper hydration can help reduce symptoms like headache and fatigue, which are sometimes associated with immune responses.

Take with Food: If gastrointestinal symptoms occur, taking TA-1 with food may help minimize these effects.

Monitor Immune Response: Regular follow-ups with a healthcare provider are essential to ensure optimal dosing and to monitor for any adverse reactions.

1-2 Weeks: Users may begin to notice improvements in energy levels and a reduction in the frequency of infections as immune function is enhanced.

4-6 Weeks: Significant improvements in immune cell activity and reduced oxidative stress are typically observed. Studies indicate enhanced response to vaccines and a reduction in symptoms of chronic infections.

Long-Term: Continuous use of TA-1 may lead to sustained improvements in immune resilience, enhanced response to vaccinations, and better management of chronic inflammatory conditions. Patients with viral infections may experience fewer relapses and improved overall health.

TA-1 enhances the immune system by interacting with various Toll-like receptors (TLRs), including TLR2, TLR4, and TLR9, which are involved in innate immunity. By activating these receptors, TA-1 promotes the release of key cytokines, such as interleukin-2 (IL-2) and interferon-alpha, which play a major role in immune cell activation and proliferation. TA-1 also aids in the differentiation and activation of dendritic cells, which are crucial for initiating and maintaining immune responses. By shifting the balance towards T-helper 1 (Th1) immune responses, TA-1 enhances the body's ability to combat intracellular pathogens, including viruses and certain bacteria.